Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Small extracellular vesicle microRNAs in pediatric myasthenia gravis plasma and skeletal muscle

6 Mar 2024

Abstract excerpt

BACKGROUND: The diagnosis of myasthenia gravis (MG) in children remains difficult. Circulating small extracellular vesicle (sEV)-derived miRNAs (sEV-miRNAs) have been recognized as biomarkers of various diseases and can be excreted by different cell types. These biomarker candidates also play a vital role in autoimmune diseases via intercellular communication. METHODS: In the present study, we used sEV isolation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Extracellular vesicles in disease
Share to Inflammatory Myopathies and Dermatomyositis
Share to Myasthenia Gravis and Thymoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38449066
DOI: 10.1093/postmj/qgae015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Small extracellular vesicle microRNAs in pediatric myasthenia gravis plasma and skeletal musclePMID 38449066Read ↗

Emerging Roles of Dysregulated MicroRNAs in Myasthenia GravisSemantic proximity Read ↗

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized MedicineSemantic proximity Read ↗

A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis.Semantic proximity Read ↗

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read ↗

Plasma exosomal miR‐106a‐5p expression in myasthenia gravisSemantic proximity Read ↗

Circulating microRNAs as potential biomarkers in myasthenia gravis patientsSemantic proximity Read ↗

Non-coding RNA and its network in the pathogenesis of Myasthenia GravisSemantic proximity Read ↗

Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAsSemantic proximity Read ↗

Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravisSemantic proximity Read ↗

Study of serum exosome miRNA as a biomarker for early onset adult ouclar myasthenia gravisSemantic proximity Read ↗

Serum exosomal miR‑328, miR‑575, miR‑134 and miR‑671‑5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapySemantic proximity Read ↗

Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analysesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.